Midatech Pharma welcomes Dr Dmitry Zamoryakhin as Chief Scientific Officer


20th July 2021

Dmitry is a medically trained professionalmedical doctor with over 17 years of experience in drug and medical devices development.

“It is a great pleasure and privilege to join the fantastic team at Midatech Pharma. The company’s ‘multiple shots on goal’ strategy provides for creative and highly exciting environment allowing to progress innovative approaches to possible treatment of currently incurable diseases…..” says Dmitry Zamoryakhin, CSO

Dmitry holds a MD from the Perm State Medical Academy (Russia), an MBA from the Warwick University and a diploma in pharmaceutical medicine from the Universite Libre de Bruxelles. Prior to joining Midatech Pharma, Dmitry served as a Chief Medical Officer at Oxford Biomedica plc, a company specialising in development products within the cell & gene area. He has also had roles of increasing responsibilities within GSK, Ono Pharma, Daiichi Sankyo and Grunenthal.

Commenting, Stephen Stamp, CEO and CFO of Midatech said: "I am delighted to welcome Dmitry to the Midatech team. He is a medic, was big pharma trained and has been biotech battle hardened. His breadth of experience will be invaluable as we move our Q-Sphera programmes and MTX110 through proof of concept to partnering.